DocGo (NASDAQ:DCGO - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.01), Zacks reports. DocGo had a net margin of 4.35% and a return on equity of 8.90%. The firm had revenue of $616,555.13 billion during the quarter, compared to analyst estimates of $129.42 million. DocGo updated its FY 2025 guidance to EPS.
DocGo Stock Down 3.2 %
Shares of DCGO traded down $0.10 on Monday, reaching $2.99. The stock had a trading volume of 1,555,559 shares, compared to its average volume of 729,399. The firm has a 50-day moving average of $4.58 and a 200 day moving average of $4.03. The firm has a market capitalization of $305.13 million, a PE ratio of 10.68, a PEG ratio of 14.16 and a beta of 1.00. DocGo has a twelve month low of $2.75 and a twelve month high of $5.68.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the stock. Needham & Company LLC cut their price target on shares of DocGo from $7.00 to $4.00 and set a "buy" rating for the company in a report on Friday. Stifel Nicolaus reduced their price target on DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a report on Friday. Finally, Deutsche Bank Aktiengesellschaft downgraded DocGo from a "buy" rating to a "hold" rating and decreased their price target for the company from $5.00 to $2.85 in a research note on Friday. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, DocGo presently has a consensus rating of "Moderate Buy" and an average target price of $4.89.
View Our Latest Stock Report on DCGO
Insiders Place Their Bets
In other news, General Counsel Ely D. Tendler sold 23,088 shares of DocGo stock in a transaction on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the transaction, the general counsel now owns 175,645 shares of the company's stock, valued at $779,863.80. The trade was a 11.62 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 2.70% of the stock is owned by company insiders.
DocGo Company Profile
(
Get Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Further Reading
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
